Promoting and facilitating strategies to improve cardiovascular health worldwide

 

 

 

Meeting Highlights

From the 26th Annual Scientific Meeting of the ISCP – Singapore

 

 

Tratamiento con ACOD en pacientes con FA post-ICP

ISCP On-Demand Webinar

 

 

ISCP Webinar: Cardiovascular Risk Management of Diabetes and SGLT2 Inhibitors

 

newsfeed

Access to preventive care is essential for our nation’s health: We must protect the ACA

Posted on August 09, 2022

Several health provisions guaranteed by the Affordable Care Act have been widely popular among the American people and saved countless lives ever... more

Adding ticagrelor to aspirin reduces vein graft failure, increases bleeding after CABG

Posted on August 09, 2022

Compared with aspirin alone, aspirin plus ticagrelor was associated with reduced risk for vein graft failure and increased risk for clinically important... more

Noninvasive biomarker platform for fluid assessment in HF cleared

Posted on August 09, 2022

Bodyport announced its noninvasive biomarker platform, made in the form of a scale, received FDA clearance for measurement of fluid status and... more

‘Focus on the workforce’: New AHA president outlines goals for improving research, CV care

Posted on August 09, 2022

The American Heart Association in July installed Michelle A. Albert, MD, MPH, FACC, FAHA, as its 86th president, the first woman of... more

ISCP book series

Current Cardiovascular Therapy
Kaski, Juan Carlos.

Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...

  • Antiplatelet and Anticoagulation Therapy

    A. Ferro, D.A. Garcia (Eds.)

  • Pharmacological Treatment of Acute Coronary Syndromes

    Avanzas, Pablo; Clemmensen, Peter(Eds.)

  • Atrial Fibrillation Therapy

    Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)

board of directors

Providing a leadership and advocacy role amongst members of their national societies.

 

  •   Thomas Kahan

    President

    Affiliations/Memberships Professor of Medicine Department of Clinical Sciences, Danderyd Hospital Division of Cardiovascular Medicine (more…) more

  •   Pablo Avanzas

    Secretary

    Affiliations/Memberships Consultant in Invasive Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain Fellow of (more…) more

  •   Sang Hong Baek

    VP/President Elect

    Professor Sang Hong Baek is Director of Heart Failure and Transplantation Programme and Preventive Cardiology at Seoul St. Mary's (more…) more

  •   Georg Noll

    Treasurer

      Georg Noll is a specialist in General Internal Medicine and Cardiology at Heart Clinic Zurich. He was Associate Professor of Cardiology (more…) more